PENTA15: Plasma Pharmacokinetic Study of Once Versus Twice Daily Abacavir as Part of Combination Antiretroviral Therapy in Children With HIV-1 Infection Aged 3 Months to <36 Months
Phase of Trial: Phase II
Latest Information Update: 14 May 2014
At a glance
- Drugs Abacavir (Primary) ; Lamivudine
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms PENTA15
- 20 Nov 2013 New source identified and integrated: ClinicalTrials.gov record.
- 07 Feb 2006 New trial record.